Literature DB >> 3023551

Visual evoked potentials in parkinsonism and dopamine blockade reveal a stimulus-dependent dopamine function in humans.

M Onofrj, M F Ghilardi, M Basciani, D Gambi.   

Abstract

VEPs were recorded with three different spatial frequencies of stimulation in patients affected by idiopathic Parkinsonism and by Parkinsonian syndromes. The detection of VEP abnormalities in Parkinson's disease was dependent on the spatial frequency of the visual stimulus (a vertical square wave grating). The VEP latency was normal in Parkinsonian syndrome patients (except in one patient affected by familial Parkinsonism). Dopamine precursor therapy differently reduced the VEP latency, depending on the spatial frequency of the visual stimulus. These findings suggest that the dopaminergic mechanism involved in the generation of VEP delays is sensitive to stimulus spatial frequency. The study of VEPs before and after the administration of haloperidol confirmed this hypothesis. VEP latency did not correlate with the major clinical symptoms of Parkinson's disease and could not predict the results of chronic dopaminergic therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023551      PMCID: PMC1029049          DOI: 10.1136/jnnp.49.10.1150

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  37 in total

1.  Visual evoked potentials in hemiparkinsonism.

Authors:  M Mintz; R Tomer; H Radwan; M S Myslobodsky
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1981-12

2.  [Visual evoked potentials in Parkinson's disease (author's transl)].

Authors:  P J Delwaide; B Mesraoua; V De Pasqua
Journal:  Rev Electroencephalogr Neurophysiol Clin       Date:  1980 Oct-Dec

3.  Measurements of visual evoked potentials in Parkinson's disease.

Authors:  I Bodis-Wollner; M D Yahr
Journal:  Brain       Date:  1978-12       Impact factor: 13.501

4.  Visual and auditory evoked responses in patients with Parkinson's disease.

Authors:  M J Gawel; P Das; S Vincent; F C Rose
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-03       Impact factor: 10.154

5.  Visual system abnormalities in patients with Parkinson's disease.

Authors:  M J Kupersmith; E Shakin; I M Siegel; A Lieberman
Journal:  Arch Neurol       Date:  1982-05

6.  The effect of levodopa treatment on the visual evoked potentials in Parkinsonian patients.

Authors:  I Yaar
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1980-11

7.  Dementia in Parkinson disease: a neuropathologic study.

Authors:  A M Hakim; G Mathieson
Journal:  Neurology       Date:  1979-09       Impact factor: 9.910

8.  Visual involvement in Friedreich's ataxia and hereditary spastic ataxia. A clinical and visual evoked response study.

Authors:  I R Livingstone; F L Mastaglia; R Edis; J W Howe
Journal:  Arch Neurol       Date:  1981-02

9.  The incidence and nature of visual pathway involvement in Friedreich's ataxia. A clinical and visual evoked potential study of 22 patients.

Authors:  W M Carroll; A Kriss; M Baraitser; G Barrett; A M Halliday
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

10.  Pattern-reversal visual evoked potentials in the hereditary ataxias and spinal degenerations.

Authors:  T D Bird; W E Crill
Journal:  Ann Neurol       Date:  1981-03       Impact factor: 10.422

View more
  19 in total

1.  Simultaneous VEP and PERG investigations in early Parkinson's disease.

Authors:  S Calzetti; A Franchi; G Taratufolo; E Groppi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-02       Impact factor: 10.154

2.  Visual evoked potentials and pattern electroretinograms in Parkinson's disease and control subjects.

Authors:  A Tartaglione; A Oneto; F Bandini; E Favale
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

3.  Associated central and peripheral demyelination: an electrophysiological study.

Authors:  A Uncini; M Treviso; M Basciani; M Onofrj; D Gambi
Journal:  J Neurol       Date:  1988-03       Impact factor: 4.849

4.  The effect of docosahexaenoic Acid on visual evoked potentials in a mouse model of Parkinson's disease: the role of cyclooxygenase-2 and nuclear factor kappa-B.

Authors:  Ozlem Ozsoy; Gamze Tanriover; Narin Derin; Nimet Uysal; Necdet Demir; Burcu Gemici; Ceren Kencebay; Piraye Yargicoglu; Aysel Agar; Mutay Aslan
Journal:  Neurotox Res       Date:  2011-01-14       Impact factor: 3.911

Review 5.  The retina as a window to the brain-from eye research to CNS disorders.

Authors:  Anat London; Inbal Benhar; Michal Schwartz
Journal:  Nat Rev Neurol       Date:  2012-11-20       Impact factor: 42.937

6.  Source model and scalp topography of pattern reversal visual evoked potentials to altitudinal stimuli suggest that infoldings of calcarine fissure are not part of VEP generators.

Authors:  M Onofrj; T Fulgente; A Thomas; G Malatesta; M Peresson; T Locatelli; V Martinelli; G Comi
Journal:  Brain Topogr       Date:  1995       Impact factor: 3.020

7.  Subclinical visual impairment in phenylketonuria. A neurophysiological study (VEP-P) with clinical, biochemical, and neuroradiological (MRI) correlations.

Authors:  V Leuzzi; S Rinalduzzi; F Chiarotti; P Garzia; G Trasimeni; N Accornero
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

Review 8.  Retinopathy in Parkinson Disease.

Authors:  Ivan Bodis-Wollner
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

Review 9.  Neuroprotective strategies for retinal disease.

Authors:  Machelle T Pardue; Rachael S Allen
Journal:  Prog Retin Eye Res       Date:  2018-02-23       Impact factor: 21.198

10.  Visual dysfunction in treated schizophrenia suggested by visual evoked potentials from pattern-reversal stimulation.

Authors:  I Jibiki; Y Takizawa; N Yamaguchi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.